Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2013



Summary



GlobalData's clinical trial report, “Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2013" provides data on the Peripheral Neuropathy (Sensory Neuropathy) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Peripheral Neuropathy (Sensory Neuropathy). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Peripheral Neuropathy (Sensory Neuropathy). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Scope


- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)



Reasons to buy


- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Peripheral Neuropathy (Sensory Neuropathy) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 21
Clinical Trials in E7 Nations by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Unaccomplished Trials of Peripheral Neuropathy (Sensory Neuropathy) 26
Subjects Recruited Over a Period of Time 30
Prominent Sponsors 31
Top Companies Participating in Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials 33
Prominent Drug Comparison 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Pfizer Inc. 36
Clinical Trial Overview of Pfizer Inc. 36
NeurogesX, Inc. 37
Clinical Trial Overview of NeurogesX, Inc. 37
GW Pharmaceuticals plc 38
Clinical Trial Overview of GW Pharmaceuticals plc 38
Johnson and Johnson 39
Clinical Trial Overview of Johnson and Johnson 39
CSL Behring LLC 40
Clinical Trial Overview of CSL Behring LLC 40
Origin BioMed, Inc. 41
Clinical Trial Overview of Origin BioMed, Inc. 41
Endo Pharmaceuticals Inc. 42
Clinical Trial Overview of Endo Pharmaceuticals Inc. 42
Protemix Corporation Limited 43
Clinical Trial Overview of Protemix Corporation Limited 43
Neurotune AG 44
Clinical Trial Overview of Neurotune AG 44
Eisai Inc. 45
Clinical Trial Overview of Eisai Inc. 45
Lupin Limited 46
Clinical Trial Overview of Lupin Limited 46
Merck KGaA 47
Clinical Trial Overview of Merck KGaA 47
Sigma-Tau S.p.A. 48
Clinical Trial Overview of Sigma-Tau S.p.A. 48
Bristol-Myers Squibb Company 49
Clinical Trial Overview of Bristol-Myers Squibb Company 49
Octapharma AG 50
Clinical Trial Overview of Octapharma AG 50
Laboratorios Del Dr. Esteve S.A. 51
Clinical Trial Overview of Laboratorios Del Dr. Esteve S.A. 51
Cubist Pharmaceuticals, Inc. 52
Clinical Trial Overview of Cubist Pharmaceuticals, Inc. 52
Astellas Pharma Inc. 53
Clinical Trial Overview of Astellas Pharma Inc. 53
Grifols, S.A. 54
Clinical Trial Overview of Grifols, S.A. 54
Otsuka Pharmaceutical Co., Ltd. 55
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 55
Clinical Trial Overview of Top Institutes / Government 56
The University of Texas M. D. Anderson Cancer Center 56
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 56
Odense University Hospital 57
Clinical Trial Overview of Odense University Hospital 57
National Taiwan University Hospital 58
Clinical Trial Overview of National Taiwan University Hospital 58
The National Institute of Allergy and Infectious Diseases 59
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 59
National Center for Research Resources 60
Clinical Trial Overview of National Center for Research Resources 60
Washington University School of Medicine 61
Clinical Trial Overview of Washington University School of Medicine 61
Northwestern University 62
Clinical Trial Overview of Northwestern University 62
Erasmus MC 63
Clinical Trial Overview of Erasmus MC 63
Mayo Clinic 64
Clinical Trial Overview of Mayo Clinic 64
Johns Hopkins University 65
Clinical Trial Overview of Johns Hopkins University 65
Assistance Publique - Hopitaux de Paris 66
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 66
The University of Auckland 67
Clinical Trial Overview of The University of Auckland 67
U.S. Department of Veterans Affairs 68
Clinical Trial Overview of U.S. Department of Veterans Affairs 68
National Center for Complementary and Alternative Medicine 69
Clinical Trial Overview of National Center for Complementary and Alternative Medicine 69
Oregon Health and Science University 70
Clinical Trial Overview of Oregon Health and Science University 70
Columbia University 71
Clinical Trial Overview of Columbia University 71
Virginia Commonwealth University 72
Clinical Trial Overview of Virginia Commonwealth University 72
Skane University Hospital 73
Clinical Trial Overview of Skane University Hospital 73
National Institute of Neurological Disorders and Stroke 74
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 74
H. Lee Moffitt Cancer Center and Research Institute 75
Clinical Trial Overview of H. Lee Moffitt Cancer Center and Research Institute 75
Five Key Clinical Profiles 76
Appendix 200
Abbreviations 200
Definitions 200
Research Methodology 201
Secondary Research 201
About GlobalData 202
Contact Us 202
Disclaimer 202
Source 203

List of Tables

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Zone, 2013* 9
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 12
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 13
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, North America, Top Countries, 2013* 14
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 15
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 16
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, BRIC Countries, 2013* 17
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, G7 Countries, 2013* 18
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 20
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, E7 Countries, 2013* 21
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 22
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Phase, 2013* 23
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 24
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 25
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Suspended Clinical Trials, 2013* 26
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 27
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Terminated Clinical Trials, 2013* 28
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 30
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 32
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 34
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 35
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 36
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by NeurogesX, Inc., 2013* 37
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals plc, 2013* 38
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2013* 39
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Behring LLC, 2013* 40
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Origin BioMed, Inc., 2013* 41
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo Pharmaceuticals Inc., 2013* 42
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Protemix Corporation Limited, 2013* 43
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurotune AG, 2013* 44
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2013* 45
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Lupin Limited, 2013* 46
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck KGaA, 2013* 47
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sigma-Tau S.p.A., 2013* 48
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2013* 49
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Octapharma AG, 2013* 50
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorios Del Dr. Esteve S.A., 2013* 51
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cubist Pharmaceuticals, Inc., 2013* 52
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2013* 53
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2013* 54
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2013* 55
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2013* 56
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2013* 57
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 58
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2013* 59
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2013* 60
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2013* 61
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2013* 62
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2013* 63
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 64
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013* 65
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013* 66
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Auckland, 2013* 67
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2013* 68
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Complementary and Alternative Medicine, 2013* 69
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2013* 70
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2013* 71
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Virginia Commonwealth University, 2013* 72
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Skane University Hospital, 2013* 73
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2013* 74
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center and Research Institute, 2013* 75

List of Figures

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 9
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 12
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 13
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 14
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 15
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 16
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, BRIC Countries (%), 2013* 17
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, G7 Countries (%), 2013* 18
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, E7 Countries (%), 2013* 21
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 22
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 23
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 24
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 25
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 30
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 31
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 33
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 35
GlobalData Methodology 201

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Enabling Technological Platforms for Lab-on-Chip Applications  (Technical Insights)

Enabling Technological Platforms for Lab-on-Chip Applications (Technical Insights)

  • $ 6 500
  • Industry report
  • June 2014
  • by Frost & Sullivan

6 Dimensional Assessment of Lab on a Chip Innovation Landscape A growing trend towards miniaturizing laboratory practices has been a major driving force behind the steady increase of innovations in the ...

Biologicals in Oncology Drug Pipeline Update 2014

Biologicals in Oncology Drug Pipeline Update 2014

  • $ 3 749
  • Industry report
  • July 2014
  • by Bioseeker

This drug pipeline update covers a wide array of biological drugs, such as: antibodies,proteins, peptides, DNA, RNA and cellular therapies. There are today 908 companies plus partners developing 1686 biological ...

Biologicals in Oncology: Drug Pathway Analyzer 2014

Biologicals in Oncology: Drug Pathway Analyzer 2014

  • $ 3 675
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 1421 biological drugs known to affect more than 266 specific intracellular signaling pathways for the treatment ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.